Cargando…

Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial

BACKGROUND: No approved treatment is available for patients with vascular cognitive impairment (VCI) due to cerebral small vessel disease (SVD). OBJECTIVE: The CONIVaD (Choline Alphoscerate and Nimodipine in Vascular Dementia) study aimed to investigate the feasibility, efficacy, and safety of a com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvadori, Emilia, Poggesi, Anna, Donnini, Ida, Rinnoci, Valentina, Chiti, Guido, Squitieri, Martina, Tudisco, Laura, Fierini, Fabio, Melone, Anna, Pescini, Francesca, Pantoni, Leonardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211589/ https://www.ncbi.nlm.nih.gov/pubmed/33855653 http://dx.doi.org/10.1007/s40266-021-00852-8

Ejemplares similares

Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain
por: Tayebati, Seyed Khosrow, et al.
Publicado: (2017)

Effect of Choline Alphoscerate on the Survival of Glioblastoma Patients: A Retrospective, Single-Center Study
por: Kim, Yeong Jin, et al.
Publicado: (2022)

Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer’s Disease
por: Carotenuto, Anna, et al.
Publicado: (2022)

Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis
por: Sagaro, Getu Gamo, et al.
Publicado: (2023)

Association Between Motor and Cognitive Performances in Elderly With Atrial Fibrillation: Strat-AF Study
por: Salvadori, Emilia, et al.
Publicado: (2020)

Role of Biological Markers for Cerebral Bleeding Risk STRATification in Patients with Atrial Fibrillation on Oral Anticoagulants for Primary or Secondary Prevention of Ischemic Stroke (Strat-AF Study): Study Design and Methodology
por: Poggesi, Anna, et al.
Publicado: (2019)

P300 latency changes in patients with mild cognitive impairment after taking choline alphoscerate; A preliminary study
por: Han, Su-Hyun, et al.
Publicado: (2018)

Intravenous thrombolysis in CADASIL: report of two cases and a systematic review
por: Pescini, Francesca, et al.
Publicado: (2022)

Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study
por: Salvadori, Emilia, et al.
Publicado: (2021)

Comparison between Ischemic and Hemorrhagic Strokes in Functional Outcome at Discharge from an Intensive Rehabilitation Hospital
por: Salvadori, Emilia, et al.
Publicado: (2020)

Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment
por: Pantoni, Leonardo, et al.
Publicado: (2019)

Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience
por: Donnini, Ida, et al.
Publicado: (2012)

Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt Study
por: Pantoni, Leonardo, et al.
Publicado: (2017)

The Role of Extracellular Matrix and Inflammation in the Stratification of Bleeding and Thrombotic Risk of Atrial Fibrillation on Oral Anticoagulant Therapy: Insights from Strat-Af Study
por: Alfano, Francesco, et al.
Publicado: (2023)

The clinical profile of cerebral small vessel disease: Toward an evidence‐based identification of cognitive markers
por: Salvadori, Emilia, et al.
Publicado: (2022)

Fractal dimension of the cortical gray matter outweighs other brain MRI features as a predictor of transition to dementia in patients with mild cognitive impairment and leukoaraiosis
por: Marzi, Chiara, et al.
Publicado: (2023)

Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients
por: Nannucci, Serena, et al.
Publicado: (2018)

Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers—The VMCI-Tuscany Study: Rationale, Design, and Methodology
por: Poggesi, Anna, et al.
Publicado: (2012)

Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients
por: Salvadori, Emilia, et al.
Publicado: (2018)

Can CHA(2)DS(2)-VASc and HAS–BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat–AF Study
por: Bianconi, Elisa, et al.
Publicado: (2022)

Thunderclap headache triggered by micturition: responsive to nimodipine
por: Han, Yuan-Yuan, et al.
Publicado: (2011)

Nimodipine Reappraised: An Old Drug with a Future
por: Carlson, Andrew P., et al.
Publicado: (2020)

Nimodipine Pharmacokinetic Variability in Various Patient Populations
por: Mahmoud, Sherif Hanafy, et al.
Publicado: (2020)

Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes
por: Novac, Marian, et al.
Publicado: (2022)

Teleneuropsychology for vascular cognitive impairment: Which tools do we have?
por: Salvadori, Emilia, et al.
Publicado: (2023)

Nimodipine in otolaryngology: from past evidence to clinical perspectives
por: MONZANI, D., et al.
Publicado: (2015)

Nimodipine Reduces Dysfunction and Demyelination in Models of Multiple Sclerosis
por: Desai, Roshni A., et al.
Publicado: (2020)

Blood Pressure Changes in Association with Nimodipine Therapy in Patients with Spontaneous Subarachnoid Hemorrhage
por: Rass, Verena, et al.
Publicado: (2023)

Intravenous nimodipine worsening prolonged attack of familial hemiplegic migraine
por: Mjåset, Christer, et al.
Publicado: (2008)

Continuous Local Intra-Arterial Nimodipine for the Treatment of Cerebral Vasospasm
por: Logallo, Nicola, et al.
Publicado: (2015)

Hot spots and future directions of research on the neuroprotective effects of nimodipine
por: Li, Runhui
Publicado: (2014)

A dilemma regarding the optimal administration of nimodipine in the subarachnoid hemorrhage
por: Tykocki, Tomasz
Publicado: (2015)

In vitro and in vivo evaluation of hypothermia on pharmacokinetics and pharmacodynamics of nimodipine in rabbits
por: Fei, Yu-xing, et al.
Publicado: (2017)

Efficacy of nimodipine in the treatment of subarachnoid hemorrhage: a meta-analysis
por: Liu, Jianqiang, et al.
Publicado: (2022)

Protective effects of choline against hypoxia-induced injuries of vessels and endothelial cells
por: Zhang, Lian-Cheng, et al.
Publicado: (2017)

One-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine
por: Luo, Jing-Wen, et al.
Publicado: (2016)

Effect of age on the pharmacokinetics of polymorphic nimodipine in rats after oral administration
por: Liu, Wenli, et al.
Publicado: (2016)

Recovery of Voice After Reconstruction of the Recurrent Laryngeal Nerve and Adjuvant Nimodipine
por: Mattsson, P., et al.
Publicado: (2017)

Nimodipine treatment does not benefit juvenile ferrets with kaolin-induced hydrocephalus
por: Di Curzio, Domenico L., et al.
Publicado: (2018)

Effect of hyperbaric oxygen combined with nimodipine on treatment of diffuse brain injury
por: Sun, Jianping, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4mcace672itjqne7ifsa43urnj